Table 4.

Local outcome and palliative effects

	All patients	Recurrence Treatment Group	Primary Treatment Group
End of HT	n = 26	n = 12	n = 14
Local partial remission	6 (23%)	4 (33%)	2 (14%)
Local complete remission	−	−	−
Local stable disease	20 (76%)	6 (50%)	12 (85%)
Local progression	2 (8%)	2 (17%)	0
Systemic progression	4 (15%)	2 (17%)	2 (14%)
Acute symptom relief	7 (27%)	5 (42%)	2 (14%)
6–8 weeks after HT	n = 23	n = 12	n = 11
Local partial remission	8 (35%)	6 (50%)	2 (18%)
Local complete remission	4 (18%)	4 (33%)	−
Local stable disease	7 (30%)	−	7 (64%)
Local progression	1 (4%)	−	1 (9%)
Systemic progression	3 (13%	2 (17%)	1 (9%)
Lost to follow up	2	−	2
Deceased	1	−	1
3–4 months after HT	n = 17	n = 8	n = 9
Local partial remission	2 (11%)	−	2 (22%)
Local complete remission	−	−	−
Local stable disease	7 (42%)	3 (38%)	4 (44%)
Local progression	3 (18%)	1 (13%)	2 (22%)
Systemic progression	5 (29%)	4 (50%)	1 (11%)
Lost to follow up	6	2	4
Deceased	3	2	1